A Mini Review on the Phytochemistry, Toxicology and Antiviral Activity of Some Medically Interesting Zingiberaceae Species
Clément M. Mbadiko, Clément L. Inkoto, Benjamin Z. Gbolo, Emmanuel M. Lengbiye, Jason T. Kilembe, Aristote Matondo, Domaine T. Mwanangombo, Etienne M. Ngoyi, Gédéon N. Bongo, Clarisse M. Falanga, Damien S. T. Tshibangu, Dorothée D. Tshilanda, Koto-Te-Nyiwa Ngbolua, Pius T. Mpiana
Journal of Complementary and Alternative Medical Research · pp. 44–56 · Published 11 Jun 2020
10.9734/jocamr/2020/v9i430150Abstract
Background: Plants of the Zingiberaceae family namely Curcuma longa, Aframomum melegueta and Zingiber officinale are known for their many biological activities such as the antiviral activity. Aim: To provide an updated knowledge on the phytochemistry, toxicology and antiviral activity of some medically interesting Zingiberaceae species. Study Design: Multidisciplinary advanced bibliographic surveys and dissemination of the resulted knowledge. Results: The literature review shows that these edible plants have antiviral properties on different types of viruses ( Rhinovirus, hepatitis B and C viruses, Herpes simplex viruses type 1 and 2, Human immunodeficiency viruse, Enterovirus 71, Ebola Virus, Human cytomegalovirus, Chikungunya virus, Epstein-Barr Virus, Japanese Encephalitis Virus, Respiratory syncytial virus, Fish viral hemorrhagic septicemia virus, Influenza A virus, Epstein-Barr virus, Coronavirus SARS-CoV-1, etc.). In addition, the literature indicated that these plants are a significant source of nutrients, which can boost the immune system and are safe according to the existing toxicological data. Conclusion: The present mini-review can therefore help to inform future scientific research towards the development of antiCovid-19 herbal drugs of relevance as well as nutraceuticals from these three plants species for the improvement of human health and wellbeing using reverse pharmacology approach. Molecular docking of some naturally occurring isolate compounds against SARS-CoV-2 proteases is in progress.
Cited by 30
D. Tshibangu, A. Matondo, E. Lengbiye · 2020
Z. Basharat, M. Jahanzaib, Noor Rahman · 2020
Z. Basharat, M. Jahanzaib, Noor Rahman · 2020
Modeste Ndaba Modeawi, R. D. Djoza, C. Ashande · 2020
Mbadiko, Matondo, TJ Kilembe · 2022
Vinod Kumar Gurjar · Reference Series in Phytochemistry · 2023
Clément Mbadiko, Koto-te-Nyiwa Ngbolua, Gédéon Bongo · 2024
Thahiya Naushad, Irfan Türetgen, Shiburaj Sugathan · Sustainable Development and Biodiversity · 2023
Vinod Kumar Gurjar · Reference Series in Phytochemistry · 2023
Namık Kılınç, Mikail Açar, Salih Tuncay · Letters in Drug Design & Discovery · 2022
Related research
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Assessment of Anxiety in Healthcare Providers Working in ICU during COVID-19 Pandemics — shares topic coverage
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
- Elevated Levels of Lactate Dehydrogenase Predicts Poor Outcomes for Patients with COVID-19: A Review — shares topic coverage
- Addressing the Challenges of Containing Covid-19 Spread in a Rural, Poor Area in India: A Case Study — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
30
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.